Bacteriophages
- General bacteriology
Viruses that infect only bacteria. Some burst their host; others hide in its DNA and can hand it toxin genes. They are being studied as therapy.
What it is
Bacteriophages (phages) are viruses that infect bacteria and cannot infect human cells. Lytic phages multiply and burst the host, while temperate phages can instead insert their genome into the bacterial chromosome as a prophage and be copied with it (lysogeny). Prophages explain several toxin diseases and move genes between bacteria; strictly lytic phages are studied as a treatment for resistant infections.
Structure
- Head (capsid) of protein that holds the genome, most often double-stranded DNA
- Tail, often contractile, that injects the genome through the bacterial wall
- Tail fibres that bind specific receptors on the bacterial surface, which sets the narrow host range
Step by step
- Adsorption: tail fibres bind a specific receptor on the bacterium
- Injection: the genome enters; the empty capsid stays outside
- Decision: a lytic phage takes over the cell; a temperate phage may integrate as a prophage
- Lytic cycle: phage genes copy the genome and make capsid proteins
- Assembly: new genomes are packaged into heads and tails are attached
- Lysis: phage enzymes (holins and endolysins) break the wall and release new phages
- Lysogeny: the prophage is copied with the chromosome, kept silent by a repressor
- Induction: DNA damage (UV light, some antibiotics) switches the prophage to the lytic cycle
Phage-encoded toxins (lysogenic conversion)
| Bacterium | Phage-encoded product | Disease |
|---|---|---|
| Corynebacterium diphtheriae | Diphtheria toxin (tox gene) | Diphtheria |
| Vibrio cholerae O1/O139 | Cholera toxin (CTX phage) | Cholera |
| Shiga toxin-producing E. coli | Shiga toxins 1 and 2 | Bloody diarrhoea and haemolytic uraemic syndrome |
| Clostridium botulinum | Botulinum toxins C and D | Botulism (mostly in animals) |
| Streptococcus pyogenes | Streptococcal pyrogenic (erythrogenic) exotoxins | Scarlet fever, streptococcal toxic shock |
Clinical notes
- Some antibiotics can induce Shiga toxin prophages and raise toxin release, one reason antibiotics are generally avoided in Shiga toxin-producing E. coli diarrhoea
- Phage therapy uses strictly lytic phages chosen for the patient's strain; it remains experimental or compassionate use in most countries
- Limits of phage therapy: narrow host range, bacterial resistance to phages, immune clearance, endotoxin release after lysis and few controlled trials
- Phage typing (sorting strains by the phages that lyse them) was used for S. aureus and Salmonella Typhi outbreaks; molecular typing has replaced it
Common traps
- Phages can infect human cells: they infect only bacteria, binding receptors on the bacterial surface that human cells do not have.
- Any phage that kills the target bacterium in the lab is suitable for therapy: temperate phages may integrate instead of killing and can carry toxin or resistance genes, so only strictly lytic phages are used.
- Antibiotics are always harmless in Shiga toxin-producing E. coli diarrhoea: some antibiotics induce the Shiga toxin prophage and raise toxin release, one reason they are generally avoided.
- A prophage is an inert passenger: its genes can be expressed and change the bacterium (diphtheria, cholera and Shiga toxins), and DNA damage can switch it back to the lytic cycle.
- One phage preparation can treat many bacterial species: host range is narrow because tail fibres bind specific receptors, so phages are chosen against the patient's own strain.
Test yourself
Think of the answer, then tap the question to see it.
Two strains of C. diphtheriae are isolated, and only one causes diphtheria. What genetic difference is the likeliest explanation?
Only the toxigenic strain is lysogenized by the corynebacteriophage that carries the tox gene; the other lacks that prophage and makes no toxin.
A child with Shiga toxin-producing E. coli diarrhoea is given an antibiotic and then develops haemolytic uraemic syndrome. Which phage mechanism may have contributed?
Some antibiotics induce the Shiga toxin prophage into the lytic cycle, raising toxin production and release; this is one reason antibiotics are generally avoided here.
A team plans phage therapy for a resistant Pseudomonas infection. Why must candidate phages be tested against the patient's own isolate?
Host range is narrow: tail fibres bind specific receptors, so a phage that lyses one strain may not touch another, and bacteria can also become resistant to phages.
Why is a temperate phage rejected for therapy even when it lyses the target strain in the lab?
It may integrate as a prophage instead of killing, and it can move toxin or resistance genes between bacteria.
What keeps a prophage silent, and what switches it into the lytic cycle?
A phage repressor keeps it silent; DNA damage, for example from UV light or some antibiotics, inactivates the repressor and triggers induction.
Connections
Educational content on microorganisms; not a treatment guide and no substitute for a health professional's advice. No doses are given.
Sources: Limitations of Phage Therapy and Corresponding Optimization Strategies: A Review (Molecules (MDPI), 2022); Chapter 7: Diphtheria | Pink Book | CDC (Centers for Disease Control and Prevention (CDC), 2024); Horizontal Gene Transfer (Evolution, Medicine, and Public Health (Burmeister AR), 2015).
Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake
Representative model, for educational purposes only.
